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tion (PCI); it has reduced the rate of in-stent restenosis and re-
peated revascularization as compared with bare metal stents.
However, stent thrombosis is an uncommon but serious complica-
tion of coronary artery stents that almost always presents as death
or a large non-fatal myocardial infarction (MI), usually with ST
elevation.
Objective: To study the incidence of stent thrombosis which can
occur acutely (within 24 h), sub acutely (within 30 days), or as late
as 1 year (late) or more (very late) in our patients, who underwent
PCI using both DES and BMS.
Methods: Observational, single center study in cath lab a total
of 1386 patients underwent Percautaneous coronary intervention
PCI between January 2008 and September 2010, all patients in
that period were included in this study, Acute coronary syndrome
and stable CAD patients.
Results: Total of 1386 patients had PCI and stents deployment,
19 (1.3%) patients had stent thrombosis, 4 (21%) patient received
BMS and 15 (79%) patients received DES Acute ST in 4 patients,
Subacute ST in 5 patients, late ST in 8 patients and very late in 2
patients. 9 patients (47%) have DM and 8 patients (42%) have
Hypertension.
Conclusion: The incidence of ST in our Saudi patients who re-
ceived DES is similar to international reported numbers. There is
increasing concern that the risk for late stent thrombosis is slightly
higher with DES than BMS.
doi:10.1016/j.jsha.2011.02.066
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Objectives: To estimate the prevalence of any degree of Renal
Arteries Stenosis (RAS) in Hypertensive Saudi Patients undergo-
ing indicated coronary angiography (CA), and to assess the asso-
ciation of RAS with coronary Artery Disease (CAD), and vice
versa.
Methods: A prospective randomized pilot study looked at
Screening Drive-by Selective Renal Artery Angiography
(SDSRAA) performed with additional 12 ml dye in average at the
time of Cardiac Catheterization (CC) to assess the occult renal
artery stenosis of 126 diagnosed, and treated Hypertensive-Saudi
Patients who were admitted at Cardiac Science Department in Al-
Hada Military Hospital/Taif in the period between (April, 2009
and January, 2010) for chest pain and indicated for coronary angi-
ography according to ACC/AHA and/or ESC/EAPCI Guidelines.
Results: Over the ten month period 126 patients, mean age
60.4 ± 12.27 years, were recruited. All of them underwent com-
bined CA, and SDSRAA. Eighty-nine were males (70.1%). Occult
RAS with various degrees were reported in 15 patients (11.9%).
Signiﬁcant RAS (P50% luminal stenosis) found in (5.6%), and
bilateral RAS in (3.17%).Signiﬁcant CAD reported in 74 patients
(58.7%), RAS reported in patients with diseased, and normal or
nearly normal coronaries at rates 17.56% and 3.8% respectively,
while CAD reported in (86.6%) of Patients with RAS
(OR= 7.93, 95% CI = 1.58, 53.53). No signiﬁcant deference in
Serum Creatinin pre and 24–48 h post procedure. No procedure-
related technical or clinical complications had been reported.
Conclusion: Renal artery stenosis frequently associated with
hypertension and coronary artery disease. In selected hypertensive
patients undergoing cardiac catheterization screening renal artery
angiography by selective drive-by renal angiography may be prac-
tical and safe in detecting incidental renal artery stenosis which
might need corrective treatment. Further clinical outcome studies
are strongly required to support this strategy.
doi:10.1016/j.jsha.2011.02.067
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Objective: To evaluate the short and long term outcome of the
Biodegradable coated Inﬁnniumª (Paclitaxel coronary stainless
steel DES) compared to Supralimusª (Sirolimus coronary stain-
less steel DES), and Supralimus Coreª (Sirolimus coronary cobalt
chromium DES) in patients from daily practice.
Methods: Registry included 903, consecutive, non-randomized
patients, with total of 1574 stents (465 Inﬁnniumª, 442 Suprali-
musª, and 667 Supralimus Coreª implanted, in three centers.
Study design: Open label, non-randomized, prospective, multi-
center registry, between July 2004, till October 2010.
Demographic, angiographic, and followup data:
The registry included 903 patients treated over a period of 2–
5 years, in three centers. 81.6% were males, 53.5% diabetics,
64% hyperlipidemics, 58% hypertensives, and 52% smokers, with
mean age of 55 ± 10 (32–88 years).
Clinical presentation was with UAP, NSTEMI, and STEMI in
39%, 14%, and 15% consecutively. The use of CIIBIIa inhibitors
was in 72% of patients.
The lesions were in small vessels in 36%, long (47%), and cal-
ciﬁed in 21%, with mean vessel diameter of 3 ± 0.5mm, and mean
length 22 ± 7 mm.
Success of deployment was 99%, with Acute MACCE 0.9%,
and long term MACCE 6.8% Detailed group data will be
presented.
Conclusion: The acute and upto 3 years followup data clearly
shows the safety of the stents, both on short and long term periods.
Despite the non-selectivity of the patients, complexity of the lesions
treated, and high prevalence of Diabetes, small vessels and long le-
sions treated, hyperlipidemia, and patients with acute coronary
syndrome , the followup data proove efﬁcacy and non-inferiority
compared to data from the literature on similar DES.
doi:10.1016/j.jsha.2011.02.068
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Objectives: Limited data is available on High risk Multi-Vessel
PCI (HRMV-PCI) when compared with Medical Therapy(MT)
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